PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26625196-10	2016	Overexpression of molecular biomarkers of increased angiogenesis, EGFR and immune checkpoints provides novel targeted therapy options in malignant phyllodes tumors of the breast.	phyllodes	147-156	epidermal growth factor receptor	Homo sapiens	66-70	
18032821-0	2007	Egfr amplification specific gene expression in phyllodes tumours of the breast.	phyllodes	47-56	epidermal growth factor receptor	Homo sapiens	0-4	
18032821-2	2007	METHODS: In order to gain further insights into regulation mechanisms associated with egfr amplifications and EGFR expression in phyllodes tumours, we performed global gene expression analysis (Affymetrix A133.2) on a series of 10 phyllodes tumours, of these three with and seven without amplifications of an important regulatory repeat in intron 1 of egfr (CA-SSR I).	phyllodes	129-138	epidermal growth factor receptor	Homo sapiens	110-114	
18032821-4	2007	RESULTS: We were able to show that the presence of egfr CA-SSR I amplifications in phyllodes tumours was associated with 230 differentially expressed genes.	phyllodes	83-92	epidermal growth factor receptor	Homo sapiens	51-55